Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jantipa Jobsri"'
Autor:
Jantipa Jobsri, Alex Allen, Deepa Rajagopal, Michael Shipton, Kostya Kanyuka, George P Lomonossoff, Christian Ottensmeier, Sandra S Diebold, Freda K Stevenson, Natalia Savelyeva
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0118096 (2015)
Induction of potent antibody is the goal of many vaccines targeted against infections or cancer. Modern vaccine designs that use virus-like particles (VLP) have shown efficacy for prophylactic vaccination against virus-associated cancer in the clinic
Externí odkaz:
https://doaj.org/article/47ed0c9573c541e4ad1d874e2b4b03b2
Autor:
Christian H. Ottensmeier, Alex Allen, Jantipa Jobsri, Chuan Wang, Yidao Wang, Natalia Savelyeva, Gareth J. Thomas
Publikováno v:
Cancer Immunology Research. 7:B139-B139
In order to develop an effective vaccination strategy for cancer, it is necessary to induce robust T-cell responses and to overcome the immunosuppressive tumor microenvironment (TME). To induce anticancer immunity, we focused on a plant viral particl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8c53d775637df0297535e2586967a1e
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b139
https://doi.org/10.1158/2326-6074.cricimteatiaacr18-b139
Autor:
Natalia, Savelyeva, Alex, Allen, Warayut, Chotprakaikiat, Elena, Harden, Jantipa, Jobsri, Rosemary, Godeseth, Yidao, Wang, Freda, Stevenson, Christian, Ottensmeier
Publikováno v:
Current topics in microbiology and immunology. 405
In the last decade, immunotherapy with monoclonal antibodies targeting immunological check points has become a breakthrough therapeutic modality for solid cancers. However, only up to 50 % of patients benefit from this powerful approach. For others v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::353bbc59912bbd1510c37535e07f5251
https://pubmed.ncbi.nlm.nih.gov/27704269
https://pubmed.ncbi.nlm.nih.gov/27704269
Autor:
Jantipa Jobsri, Christian H. Ottensmeier, Duc Bui-Minh, Victor Klimyuk, Warayut Chotprakaikiat, Freda K. Stevenson, Natalia Savelyeva, Yuri Gleba, Elena Harden, Federica Cavallo, Alex Allen
Publikováno v:
Oncoimmunology
Passive antibody therapy for cancer is an effective but costly treatment modality. Induction of therapeutically potent anticancer antibodies by active vaccination is an attractive alternative but has proven challenging in cancer due to tolerogenic pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6984974243e4772bf91480a2e3238c5c
https://pubmed.ncbi.nlm.nih.gov/27471642
https://pubmed.ncbi.nlm.nih.gov/27471642